KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) EPS (Basic) (2016 - 2025)

Emergent BioSolutions' EPS (Basic) history spans 16 years, with the latest figure at -$1.01 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 77.19% year-over-year to -$1.01; the TTM value through Dec 2025 reached $0.98, up 127.07%, while the annual FY2025 figure was $0.98, 127.22% up from the prior year.
  • EPS (Basic) reached -$1.01 in Q4 2025 per EBS's latest filing, down from $0.96 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $3.62 in Q4 2021 to a low of -$5.38 in Q2 2024.
  • Average EPS (Basic) over 5 years is -$0.88, with a median of -$0.66 recorded in 2021.
  • Peak YoY movement for EPS (Basic): plummeted 10500.0% in 2022, then soared 635.29% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at $3.62 in 2021, then tumbled by 137.02% to -$1.34 in 2022, then skyrocketed by 34.33% to -$0.88 in 2023, then surged by 35.23% to -$0.57 in 2024, then plummeted by 77.19% to -$1.01 in 2025.
  • Per Business Quant, the three most recent readings for EBS's EPS (Basic) are -$1.01 (Q4 2025), $0.96 (Q3 2025), and -$0.22 (Q2 2025).